View More

CUREXO Hosts Live Surgical Observation of CUVIS-joint for Taiwan and Japan Delegates

Key medical and industry representatives from Taiwan and Japan recently observed a live surgery utilizing the 'CUVIS-joint' robotic surgical system at Seoul Bumin Hospital. The visit included Dr. Tamaki from Taiwan, along with representatives from Kyocera, who attended to review the surgical workflow of CUVIS-joint in a real clinical setting. During the observation, participants examined the overall system operation process, from preoperative planning to the execution of the surgery itself. The delegates provided positive feedback on the stability, efficiency, and practical usability of the robotic-assisted surgical solution demonstrated in an actual clinical environment. CUREXO will continue to expand clinical observation programs and demonstration opportunities for global medical professionals and strategic partners as part of its ongoing efforts to strengthen its presence in the global medical robotics market.

View More

CUREXO Hosts Chang Gung Specialist for CUVIS-joint Demo

On May 8, Dr. Hu Chih-chien, an orthopedic specialist from Chang Gung Memorial Hospital, one of Taiwan's largest and most prestigious medical institutions, visited the headquarters of CUREXO to participate in a demonstration of the 'CUVIS-joint' robotic surgical system. The visit was organized to discuss the broader adoption of robotic-assisted surgery in the Taiwanese market and to explore potential opportunities for future collaboration. Recognized as a leading healthcare institution in Taiwan, Chang Gung Memorial Hospital's engagement highlights the growing interest in advanced orthopedic robotic technologies across Asia. CUREXO will continue to strengthen collaboration with global key opinion leaders (KOLs) and medical professionals to accelerate its presence not only in Asia but also in the global medical robotics market.

View More

CUREXO Signs Strategic Partnership with Italian Implant Manufacturer Permedica

•  Expanding supply across Italy and North Africa•  Anticipating synergies with global implant companies through an open-platform strategy CUREXO Inc., a medical robotics specialist, announced on the 30th that it has entered into a distribution agreement with Permedica S.p.A., an Italian orthopedic medical device company, for the supply and sales of its surgical robots in Italy and Morocco. [Photo = CUREXO] Jean Cho, Head of Overseas Sales at CUREXO (left), and Federico Diego Perego, CEO of Permedica (right), pose for a commemorative photo following the signing ceremony. Under the agreement, CUREXO will supply its robotic joint replacement system, CUVIS-joint, to Italy and the broader North Africa (MENA) region through Permedica's distribution network. Founded in 1986, Permedica is an Italian orthopedic implant company that operates across multiple countries through its global sales network, offering a wide range of orthopedic medical devices. The two companies recently demonstrated robotic-assisted surgery at the Mohammed VI Foundation for Sciences and Health (FM6SS) in Morocco, showcasing the synergy between CUVIS-joint's precise bone-cutting technology and Permedica's premium implant solutions. The company noted that the successful surgical demonstration attracted strong interest from local medical professionals and stakeholders. CUVIS-joint is an open-platform robotic system for joint replacement surgery, compatible with implants from multiple manufacturers. Collaboration with Permedica's implant portfolio is expected to accelerate market expansion across Europe. A CUREXO representative stated, "Through our partnership with Permedica, we have strengthened our foundation for entering the European and North African markets. We plan to accelerate our penetration of the global medical robotics market through close collaboration with local partners." Meanwhile, CUREXO continues to expand its global footprint, having obtained U.S. FDA clearance and European CE MDR certification.

View More

CUVIS-joint Robotic Joint Surgery Successfully Demonstrated at Morocco's FM6SS

CUREXO has successfully conducted a robotic orthopedic surgery demonstration using its joint surgery robot, "CUVIS-joint," at The Mohammed VI Foundation for Science and Health (FM6SS) in Morocco.FM6SS, established by the Moroccan royal family, is a leading healthcare and education hub in Africa, encompassing large-scale hospitals, medical schools, and research facilities.The demonstration was carried out in collaboration with Permedica and FM6SS, effectively showcasing the precision of robotic surgery and the synergy with premium implants.In particular, securing a reference at one of Africa's key medical hub institutions is expected to serve as an important foundation for expanding into the Middle East and Africa (MEA) market in the future.

View More

CUREXO Participates in Korea–India Business Partnership Forum

•  Participation in Korea–India Business Partnership Forum… Strengthening Local Network Based on Indian Subsidiary[Photo = Curexo] Curexo CEO Jaejun Lee (left) is explaining the artificial joint surgery robot to Minister of Trade, Industry and Energy Jeong-kwan Kim (right) at the Korea–India Business Forum.CUREXO, a medical robotics company (CEO Jaejun Lee), announced that it participated in the Korea–India Business Partnership Forum held in New Delhi, India, on the 21st, as part of its efforts to expand its local network and target the Indian medical robotics market. The event was organized by the Korea Trade-Investment Promotion Agency (KOTRA) as an economic cooperation program aligned with the bilateral summit schedule between Korea and India. Various business programs, including a signing ceremony for achievements and showcases, were held for Korean companies operating in the local market. CUREXO was invited to participate in the event as a representative advanced medical device company from Korea operating in India. During the forum, CEO Jaejun Lee met with key domestic and international stakeholders, including Minister of Trade, Industry and Energy Jeong-kwan Kim, and introduced the technological capabilities and global market achievements of the company's flagship product, the artificial joint surgery robot "CUVIS-joint." Since establishing its local subsidiary in India last year, CUREXO has been accelerating its entry into the local market and expanding cooperation with Indian medical institutions and partners, centered on its artificial joint surgery robot "CUVIS-joint." Jaejun Lee, CEO of CUREXO, stated, "India is one of the key markets with high growth potential in the global medical robotics sector," adding, "Through this forum, we will strengthen our local partnership network and further solidify our position in the global medical robotics market."

View More

CUVIS-joint Enables Successful Robotic UKA Surgery in Japan

A unicompartmental knee arthroplasty (UKA) using CUREXO's robotic joint surgery system, "CUVIS-joint," has been successfully performed in Japan.The procedure took place at Saitama Kyodo Hospital, located in Saitama Prefecture, Japan, and was led by Dr. Kuwasawa and Dr. Fukushima.CUREXO plans to strengthen its collaborative network with key medical professionals in Japan and continue expanding the orthopedic robotic surgery market by accumulating clinical cases.

View More

CUVIS Surgical Robots Demonstrated for Brazilian Orthopedic Specialist

CUREXO conducted a demonstration at its headquarters today for Dr. Paulo César Caires de Carvalho, an orthopedic specialist from Santa Casa de Montes Claros in Brazil, featuring its robotic systems "CUVIS-joint" for joint replacement surgery and "CUVIS-spine" for spinal procedures.The session was organized to showcase the functionality and precision of the robotic systems, with a focus on knee joint replacement and spine surgery.CUREXO plans to expand collaboration opportunities with medical professionals in Latin America and continue advancing into overseas markets, including Brazil.

View More

CUVIS-joint Surgical Robot Showcased at CBCJ 2026

CUREXO participated in the 20th Brazilian Congress of Knee Surgery (CBCJ), held in Campinas, São Paulo, Brazil from April 9 to 11, where it showcased its robotic joint replacement system, "CUVIS-joint."The exhibition was conducted in collaboration with its local partner, M&M Brazil (Booth #12), demonstrating CUREXO 's competitiveness in Brazil, the largest market in South America.Moving forward, CUREXO plans to continue supplying innovative surgical solutions to medical institutions worldwide through close collaboration with its global partners.

View More

CUVIS-spine Advances to Multicenter Trials as Innovative Medical Technology

CUREXO Inc. (CEO: Jaejun Lee), a medical robotics company, announced on March 27 that its spinal surgery robotic system, CUVIS-spine, has officially entered multicenter clinical trials under the Innovative Medical Technology designation. The Innovative Medical Technology program is designed to support the early adoption of new medical technologies by allowing their use in clinical settings for a limited period while verifying safety and efficacy. Technologies validated through this process may subsequently qualify for institutional adoption, including reimbursement under the national health insurance system. For this clinical study, CUREXO has completed Institutional Review Board (IRB) submissions across multiple major hospitals, including Yonsei University Severance Hospital (Sinchon), Pusan National University Yangsan Hospital, Chung-Ang University Hospital, Kangnam Sacred Heart Hospital, and Yongin Severance Hospital. All participating institutions are currently undergoing review. The company aims to complete clinical cases within the year and plans to pursue a step-by-step strategy toward broader adoption, including national health insurance reimbursement, following the completion of the multicenter trials. Notably, Professor Dong-Wook Sohn's research team at Pusan National University Yangsan Hospital, a key participating institution, was recognized for its academic excellence in the January 2026 issue of the Journal of Korean Neurosurgical Society (JKNS), where its study was selected as one of the "Most Influential Spine Research (2023–2024)." The participation of this highly regarded research team is expected to further enhance the credibility of the upcoming clinical outcomes. CUVIS-spine is a next-generation robotic system that supports precise screw placement and surgical planning in spinal procedures, contributing to improved surgical accuracy and enhanced patient safety. CUREXO has also recently accelerated its domestic market expansion by signing an exclusive distribution agreement in Korea with CGBIO Co., Ltd., a company specializing in bio-regenerative medicine, for the CUVIS-spine system. The company has already completed its first domestic installation, generating initial commercial results. Building on this milestone, both companies plan to strengthen system competitiveness through collaboration, incorporating clinical data and real-world feedback. A company official stated, "The entry of CUVIS-spine into multicenter clinical trials marks a significant milestone in demonstrating both its technological capabilities and clinical effectiveness. Following the completion of the trials within the year, we will actively pursue broader market adoption alongside establishing institutional pathways such as insurance coverage."

View More

CUVIS-joint Surgical Robot Secures U.S. FDA Approval

•  CUVIS-joint Surgical Robot Secures U.S. FDA Approval, Targeting $14.4 Billion North American Market CUREXO Inc. (KOSDAQ: 060280), a medical robotics company, announced on March 26 that its robotic system for joint replacement surgery, CUVIS-joint, has received approval from the U.S. Food and Drug Administration (FDA). The company obtained FDA clearance approximately nine months after submitting its application in July 2025, marking a significant milestone in its entry into the United States, the world's largest medical device market. The North American joint replacement market is valued at approximately USD 14.4 billion (KRW 19 trillion), accounting for over 60% of the global market. In the United States alone, more than 4.3 million joint replacement procedures are performed annually across over 1,400 hospitals, providing a stable demand base and accelerating the adoption of surgical robotics. CUVIS-joint is a fully automated robotic system designed to assist surgeons in precisely cutting bone and accurately implanting prosthetic joints based on preoperative imaging data. Built on an open-platform architecture, the system is compatible with a wide range of implants and enables patient-specific procedures, improving both surgical accuracy and efficiency. Since receiving approval from Korea's Ministry of Food and Drug Safety (MFDS) in June 2020, CUVIS-joint has continued to demonstrate its technological competitiveness in major global markets, securing regulatory approvals from Japan's PMDA in 2025 and the European CE MDR certification in 2026. Currently, CUVIS-joint is in use across more than nine countries, including India, Indonesia, Taiwan, Japan, Brazil, and Vietnam, with cumulative procedures reaching approximately 43,000 cases. Building on this global track record, the company expects to strengthen its competitiveness in the U.S. surgical robotics market, which is led by major global ps. A company official stated, "This FDA approval is particularly meaningful as it marks our entry into the United States, the world's largest medical device market. Leveraging our extensive global references and fully automated technology, we will focus on translating this milestone into tangible revenue growth in the U.S. market."